Fundz

Ceretas raised $1 million in seed funding led by Ryan Laws and Sam Wetzler to advance its ultrasound device for treating dementia.

PRIVATEFeb 21, 2025

Amount Raised

$1 Million

Round Type

Seed

BrisbaneBiotechnologyHealth CareMedicalTherapeutics

Investors

Ryan LawsSam Wetzler

Description

Australian MedTech company Ceretas has secured $1 million in seed funding to develop a portable ultrasound device aimed at treating dementia. The funding will help the company progress through clinical research and move closer to a potential IPO.

Quick answer

Ceretas raised $1 Million in a Seed round, dated February 21, 2025. Investors: Ryan Laws and Sam Wetzler. Ceretas is based in Brisbane, Queensland, Australia.

How much did Ceretas raise?
Ceretas raised $1 Million in a Seed round on February 21, 2025.
Who invested in Ceretas?
Ryan Laws and Sam Wetzler are named as investors in this round.
What does Ceretas do?
Ceretas is a medical device company developing therapeutic ultrasound technologies to address neurological illnesses such as Alzheimer's disease.
Where is Ceretas based and how big is it?
Ceretas is based in Brisbane, Queensland, Australia. Fundz records about 5 employees.
Who are the decision-makers at Ceretas?
Fundz holds 1 contact at Ceretas. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Medical and Therapeutics around the same time

Companies in the same sectors as Ceretas that raised within 45 days of this round, from Fundz verified event records.

  • Accure Therapeutics S.L raised $1.6M (Seed) on April 7, 2025.
  • Lipella Pharmaceuticals raised $9K (Seed) on March 17, 2025.
  • StimOxyGen raised $2M on March 11, 2025.
  • Monument Therapeutics raised $1.1M (Seed) on February 25, 2025.
  • Solid IO raised $839K (Seed) on February 24, 2025.
  • MAIA Biotechnology raised $4.1M (Seed) on February 18, 2025.

Who to call at Ceretas, and when

A new round usually means Ceretas is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Ceretas raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Ceretas, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Ceretas. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Ceretas

Location

Brisbane, Queensland, Australia

About

Ceretas is a medical device company developing therapeutic ultrasound technologies to address neurological illnesses such as Alzheimer's disease.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Ceretas raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Predictive Intelligence
Strategic

ML-powered predictions for Ceretas's next move

See what Strategic adds

Ceretas raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.